PANEL DISCUSSION
From Data to Impact: Using AI to Deliver an Improved HCP Experience
This panel examines how AI can connect fragmented signals, uncover missed Rx opportunities, and help teams make smarter decisions across channels. The discussion moves beyond AI hype to the operating models, measurement frameworks, and capabilities required to turn intelligence into commercial impact.
• How is pharma using AI to better understand HCP needs, and determine the next-best action across field and digital channels?
• Where can AI make the biggest difference in turning signals into smarter marketing decisions?
• What capabilities, infrastructure, and partnerships are most needed to scale AI-driven HCP engagement?
• How do you measure the impact of AI on HCP engagement and prescribing behavior?
Avinash Prabhakar, Director, US Oncology Pipeline GI Lead, GSK
Karthik Jayaraman, Head, IT - Commercialization & Digital, Tris Pharma
Philip Poulidis, CEO and Co-Founder, ODAIA
Moderated by: Joe Falcone, Principal Advisor, Falcone Business Advisors